IMFINZI 50 mg/mL concentrate for solution for infusion

Company:
AstraZeneca Pharmaceuticals (Ireland) DAC
Status:
No Recent Update
Legal Category:
Product subject to medical prescription which may not be renewed (A)
Active Ingredient(s):
Durvalumab
*Additional information is available within the SPC or upon request to the company

Licence number

Strength

ATC code

Dosage form

EU/1/18/1322/001

50 milligram(s)/millilitre

L01FF03

Concentrate for solution for infusion

EU/1/18/1322/002

50 milligram(s)/millilitre

L01FF03

Concentrate for solution for infusion